OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
25
Results
Show all
Save search
Copy query
Show results for
Unknown
(21)
Proteomics
(2)
Metabolomics
(2)
Organisms
Human CSF-associated densovirus
(1)
Homo sapiens
(1)
Repository
MetaboLights
(2)
iProX
(1)
pride
(1)
Tissue
Pluripotent stem cell
(1)
Technology Type
Mass spectrometry
(2)
Mass Spectrometry
(1)
Shotgun proteomics
(1)
Instrument Platform
Liquid Chromatography MS - negative - reverse phase
(2)
Liquid Chromatography MS - positive - reverse phase
(2)
Publication Date
2024
(2)
2022
(1)
2025
(1)
CHEBI ID
CHEBI:10070
(1)
CHEBI:10072
(1)
CHEBI:10136
(1)
CHEBI:1015
(1)
CHEBI:10219
(1)
CHEBI:102265
(1)
CHEBI:119486
(1)
CHEBI:12387
(1)
CHEBI:12962
(1)
CHEBI:131416
(1)
CHEBI:131417
(1)
CHEBI:132502
(1)
CHEBI:132503
(1)
CHEBI:132539
(1)
CHEBI:132540
(1)
CHEBI:132542
(1)
CHEBI:132543
(1)
CHEBI:132544
(1)
CHEBI:134594
(1)
CHEBI:134642
(1)
CHEBI:136224
(1)
CHEBI:136311
(1)
CHEBI:136341
(1)
CHEBI:138367
(1)
CHEBI:138453
(1)
CHEBI:138472
(1)
CHEBI:1387
(1)
CHEBI:139123
(1)
CHEBI:140366
(1)
CHEBI:140881
(1)
Metabolite Name
(+)-Norephedrine
(1)
12-Hydroxydodecanoic acid
(1)
2-Methyl-3-oxopropanoic acid
(1)
Antibiotic JI-20A
(1)
Catechol
(1)
Cytosine
(1)
D-Xylitol
(1)
D-Xylose
(1)
DG(18:0/16:0)
(1)
DG(18:0/18:0)
(1)
Dehydroepiandrosterone
(1)
Deoxyuridine
(1)
Glycyl-glycine
(1)
Hydroquinone
(1)
L-Arabinose
(1)
L-Isoleucine
(1)
L-Leucine
(1)
L-Phenylalanine
(1)
L-Proline
(1)
Maleic acid
(1)
Niacinamide
(1)
Oleic acid
(1)
PC(16:0/18:1)
(1)
PC(16:1/20:5)
(1)
PC(18:0/18:1)
(1)
TG(16:0/16:0/18:1)
(1)
TG(16:0/18:1/22:6)
(1)
TG(18:1/18:1/18:1)
(1)
TG(18:1/18:1/22:6)
(1)
TG(18:1/22:6/22:6)
(1)
Release Date
2025
(4)
2023
(4)
2021
(4)
2024
(3)
2018
(2)
2026
(1)
2020
(1)
2017
(1)
2016
(1)
Lab affiliation
Singapore Immunology Network (SIgN), Agency for Science, Technology and Research, Singapore 138648, Singapore
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Efficacy and safety of triplet regimen capecitabine, oxaliplatin, and irinotecan (XELOXIRI) as first-line chemotherapy for advanced pancreatic cancer.
Not available
S-EPMC11905668
|
biostudies-literature
Cite
YAP and TAZ are transcriptional co-activators of AP-1 proteins and STAT3 during breast cellular transformation.
Not available
S-EPMC8463077
|
biostudies-literature
Cite
CCR6 Is a Predicting Biomarker of Radiosensitivity and Potential Target of Radiosensitization in Rectal Cancer.
Not available
S-EPMC6192915
|
biostudies-literature
Cite
Apolipoprotein A-I Is a Prognosticator of Nasopharyngeal Carcinoma in the Era of Intensity-modulated Radiotherapy.
Not available
S-EPMC5858492
|
biostudies-literature
Cite
Prevalence and Genetic Characterization of
Blastocystis
in Sheep and Pigs in Shanxi Province, North China: From a Public Health Perspective.
Not available
S-EPMC10525586
|
biostudies-literature
Cite
Determining resuscitation threshold for extremely preterm infants based on the survival rates without severe neurological injury.
Not available
S-EPMC10210526
|
biostudies-literature
Cite
The Emergence of a vv + MDV Can Break through the Protections Provided by the Current Vaccines.
Not available
S-EPMC7551601
|
biostudies-literature
Cite
Natriuretic peptide receptor-C perturbs mitochondrial respiration in white adipose tissue.
Not available
S-EPMC11418126
|
biostudies-literature
Cite
Novel mutations in COL4A3, COL4A4, and COL4A5 in Chinese patients with Alport Syndrome.
Not available
S-EPMC5436713
|
biostudies-literature
Cite
Neoadjuvant chemoimmunotherapy versus neoadjuvant chemoradiotherapy in patients with borderline resectable esophageal squamous cell carcinoma.
Not available
S-EPMC12357417
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
